Skip to Main Content

Paper Details

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.
Breast Cancer Res
4
2022
Author NameAffiliation
Francesca RizzoUniversity of Salerno
Francesca RizzoGenome Research Center for Health
  • 1 - 2

Datasets

Release 1.2